Adynamic bone disease: from bone to vessels in chronic kidney disease.
about
Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease.Comparative Proteome Analysis of hAT-MSCs Isolated from Chronic Renal Failure Patients with Differences in Their Bone Turnover StatusThe Risk of Peripheral Arterial Disease after Parathyroidectomy in Patients with End-Stage Renal Disease.Sudden onset of parathyroid hormone-independent severe hypercalcemia from reversal of tumoral calcinosis in a dialysis patient.Kidney Disease Improving Global Outcomes guidelines and parathyroidectomy for renal hyperparathyroidism.Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism.Role of Vitamin D in Uremic Vascular Calcification.The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients.Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis.Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion.Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate.Management of adynamic bone disease in chronic kidney disease: A brief review.Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients.Clearance of Sclerostin, Osteocalcin, Fibroblast Growth Factor 23, and Osteoprotegerin by Dialysis.Effect of lanthanum carbonate on coronary artery calcification and bone mineral density in maintenance hemodialysis patients with diabetes complicated with adynamic bone disease: A prospective pilot study.TGF-Beta Signaling in Bone with Chronic Kidney Disease
P2860
Q30234466-39E2DAC7-5E4F-4447-A778-5E780BD2D04FQ30234751-6C8F9F60-49A5-4ACF-9391-26CD387AEB6AQ35843651-538FCAC6-4ECA-4179-B14C-1180A52AE851Q36047996-82F5C5CB-DD19-4530-9C91-1BCF9F383602Q36147549-ACBCD661-EB62-450D-A8F9-5EB0B3C4D33CQ36157050-57F743A9-9EA2-49F7-8C1A-6945CC1966DCQ36432849-F7AD752E-AD31-4A70-8BB3-DCDC8FBB50C6Q37670797-0439A091-2B82-4187-8576-53873C406DB3Q37670856-F61BC16E-7C71-4BC2-B13F-A01C22F3CB57Q38828618-AC681095-ACE3-4582-981F-43263617B797Q38828902-118C6F7F-F3B4-4BEB-8641-A3B0B9D6CBB0Q38920636-03FCD0B8-B3B2-42F9-BAEA-F7A223C996AEQ39255870-60CA2F7B-3B8C-4BC1-A545-3EC03F4BCD46Q39447041-3C4562FD-F77D-4F46-855A-28463C69B805Q41460824-971CAE02-84BC-4D0D-BCA5-45CB5CAACDA7Q42688826-B6A716B5-54C8-4A43-8BE5-4BB58EF4EAF4Q47789778-D16B2688-831D-4C91-8DD5-D4F27B959170Q48025173-9CC90864-A656-41F4-BED7-EC06CF003831Q50021375-B96CAFE1-7346-40B6-99F1-FA4DB59B0375Q58789309-CE4CAAD1-6952-4895-A5FE-5A9ECD6DA555
P2860
Adynamic bone disease: from bone to vessels in chronic kidney disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Adynamic bone disease: from bone to vessels in chronic kidney disease.
@ast
Adynamic bone disease: from bone to vessels in chronic kidney disease.
@en
Adynamic bone disease: from bone to vessels in chronic kidney disease.
@nl
type
label
Adynamic bone disease: from bone to vessels in chronic kidney disease.
@ast
Adynamic bone disease: from bone to vessels in chronic kidney disease.
@en
Adynamic bone disease: from bone to vessels in chronic kidney disease.
@nl
prefLabel
Adynamic bone disease: from bone to vessels in chronic kidney disease.
@ast
Adynamic bone disease: from bone to vessels in chronic kidney disease.
@en
Adynamic bone disease: from bone to vessels in chronic kidney disease.
@nl
P2093
P1476
Adynamic bone disease: from bone to vessels in chronic kidney disease.
@en
P2093
César Ruiz
David Goldsmith
Iara DaSilva
Jordi Bover
Pablo Ureña
Ricardo J Bosch
Vincent Brandenburg
P304
P356
10.1016/J.SEMNEPHROL.2014.09.008
P577
2014-11-01T00:00:00Z